patients followed for up to 15 years following their first dose of auto car t cell therapy
Showing 1 - 1 of 1
Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL Trial in
Enrolling by invitation
- Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy
- +4 more
- AUTO CAR T cell therapy
-
London, United Kingdom
- +3 more
Feb 2, 2022